Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pembina Pipeline: Not a Buy Yet, But Still Worth Holding
Pembina Pipeline: Not a Buy Yet, But Still Worth Holding

Pembina Pipeline Corporation PBA is a prominent midstream energy company operating across North America. Its main business revolves around moving, storing and processing oil, natural gas and natural

PANW vs. CRWD: Which Cybersecurity Stock is a Better Buy?
PANW vs. CRWD: Which Cybersecurity Stock is a Better Buy?

Palo Alto Networks PANW and CrowdStrike CRWD are both at the forefront of the cybersecurity space, playing key roles in guarding organizations from extensive cyberattacks. While Palo Alto Networks

Economic Data Deluge This Week
Economic Data Deluge This Week

Considering we have no major economic or Q2 earnings reports out ahead of today’s holiday-shortened week, it has the capacity to be quite impactful to the stock market. That’s because this is also

Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path?
Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path?

CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues for the company.

The FDA approved CorMedix’s DefenCath in late 2023 as

Transocean Plans to Sell Off Five Stacked Rigs to Streamline Fleet
Transocean Plans to Sell Off Five Stacked Rigs to Streamline Fleet

Transocean Inc. RIG, an offshore drilling contractor based in Switzerland, announced plans to offload five stacked rigs as part of its efforts to optimize its rig fleet. The rigs to be retired

C3.ai Before Q1 Earnings Release: Buy, Sell or Hold the Stock?
C3.ai Before Q1 Earnings Release: Buy, Sell or Hold the Stock?

C3.ai, Inc. AI is scheduled to report its first-quarter of fiscal 2026 results on Sept. 3, after the closing bell.In the last reported quarter, C3.ai’s top and bottom lines surpassed the Zacks

3 Stocks to Watch From a Challenging Cable Television Industry
3 Stocks to Watch From a Challenging Cable Television Industry

The Zacks Cable Television industry players are focusing on bundled offerings and on-demand programming to counter challenges from cord-cutting as consumers shift away from traditional pay-TV

Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?
Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?

Bristol Myers (BMY) has a strong oncology portfolio comprising blockbuster immune-oncology drug Opdivo, Opdivo Qvantig, and Yervoy, among others.

Opdivo is a key drug in BMY’s Growth Portfolio that

Glaukos Builds Dual Growth Engines Amid Market Headwinds
Glaukos Builds Dual Growth Engines Amid Market Headwinds

Glaukos Corporation GKOS continues to reshape the ophthalmology landscape, backed by a record-breaking first-half 2025 performance. The company posted revenues of $230.8 million, reflecting a 27.3%

How Is PPL Empowering Customers Through Energy Efficiency?
How Is PPL Empowering Customers Through Energy Efficiency?

PPL Corporation PPL aims to modernize the grid to advance electrification, and provide customers with more options to reduce energy use, including energy efficiency programs. In line with PPL's goal

MFC Outperforms Industry, Trades Near 52-Week High: Time to Hold?
MFC Outperforms Industry, Trades Near 52-Week High: Time to Hold?

Manulife Financial Corporation MFC closed at $30.75 on Friday, near its 52-week high of $33.07. This proximity underscores investor confidence. It has the ingredients for further price

Is Fund Flow Hype Real? 3 ETFs With Big Inflows in the Last Month
Is Fund Flow Hype Real? 3 ETFs With Big Inflows in the Last Month

As with individual stocks, exchange-traded funds (ETFs) offer a host of different metrics for investors to evaluate their appeal as investments. Besides portfolio and strategy, investors will also

What to Watch for From D-Wave Now That Earnings Are Done
What to Watch for From D-Wave Now That Earnings Are Done

The mid-year earnings season for D-Wave Quantum Inc. (NYSE: QBTS) has come and gone, with the quantum computing firm posting mixed results but seeing a share price spike in the days following

Does Traffic Growth Signal a Strong Holiday Setup for Costco?
Does Traffic Growth Signal a Strong Holiday Setup for Costco?

Costco Wholesale Corporation’s COST last reported quarter painted a compelling picture with strong traffic growth that could be an important signal for the holiday season. Comparable traffic, or

Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales
Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales

Eli Lilly and Company LLY has gained tremendous market value in the past 2-3 years due to the success of its popular GLP-1 drugs, Mounjaro for type II diabetes and Zepbound for obesity.

However

Dave & Buster's (PLAY) Expected to Beat Earnings Estimates: Should You Buy?
Dave & Buster's (PLAY) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Dave & Buster's (PLAY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus

Best Momentum Stock to Buy for September 2nd
Best Momentum Stock to Buy for September 2nd

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 2nd:

Sportradar Group SRAD:This company which is a provider of sports betting and

Can Korlym Drive Corcept's Growth Through the Rest of 2025?
Can Korlym Drive Corcept's Growth Through the Rest of 2025?

Corcept Therapeutics’ CORT sole-marketed drug, Korlym (mifepristone), which is approved for treating Cushing's syndrome or endogenous hypercortisolism, has been performing well. The company’s top

Is the Options Market Predicting a Spike in CGI Group Stock?
Is the Options Market Predicting a Spike in CGI Group Stock?

Investors in CGI Group, Inc. GIB need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $75.00 Put had some of the highest implied

DuPont de Nemours (DD) Just Flashed Golden Cross Signal: Do You Buy?
DuPont de Nemours (DD) Just Flashed Golden Cross Signal: Do You Buy?

DuPont de Nemours, Inc. (DD) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DD's 50-day simple moving average crossed

Can SiriusPoint (SPNT) Climb 33.55% to Reach the Level Wall Street Analysts Expect?
Can SiriusPoint (SPNT) Climb 33.55% to Reach the Level Wall Street Analysts Expect?

SiriusPoint (SPNT) closed the last trading session at $18.72, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?
Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?

Bright Minds Biosciences Inc. (DRUG) closed the last trading session at $38.89, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High?
Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High?

Shares of Integer (ITGR) have gained 1% over the past four weeks to close the last trading session at $107.87, but there could still be a solid upside left in the stock if short-term price targets

American Axle & Manufacturing (AXL) Just Flashed Golden Cross Signal: Do You Buy?
American Axle & Manufacturing (AXL) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, American Axle & Manufacturing Holdings, Inc. (AXL) is looking like an interesting pick, as it just reached a key level of support. AXL's 50-day simple moving average

Vitesse Energy (VTS) Just Flashed Golden Cross Signal: Do You Buy?
Vitesse Energy (VTS) Just Flashed Golden Cross Signal: Do You Buy?

After reaching an important support level, Vitesse Energy, Inc. (VTS) could be a good stock pick from a technical perspective. VTS recently experienced a "golden cross" event, which saw its 50-day